FDA Drug Recalls

Recalls / Generics / Methotrexate

Methotrexate

2 FDA drug recalls involving generic “Methotrexate.

DateClassProductFirm
2021-03-15Class IIMethotrexate Injection, USP 50 mg/2mL (25 mg/mL) 5 x 2mL Single-Dose Vials, Sterile, Rx Only, Distributed by HCardinal Health Inc.
2012-06-27Class IIMethotrexate Injection, USP, 25 mg/mL, 40 mL Single Dose Vial, Rx only, antineoplastic/cytotoxic agent; ManufaHospira Inc.